Clinical use of cisplatin (Cisp), one of the most widely used, common, and effective chemotherapeutic agents, is limited by its side effects, particularly tubular injury-associated nephrotoxicity. Previous studies suggest that hydrogen sulfide (H2S) alleviates Cisp-induced acute kidney injury (AKI). However, the underlying mechanism remains largely unclear.
Results:
A single intraperitoneal injection of Cisp is employed to induce AKI, and the mice exhibit severe kidney dysfunction and histological damage at day 4 after Cisp injection. Here, we reported that H2S alleviated Cisp-caused renal toxicity via SIRT3 activation and subsequent improvement of mitochondrial ATP production. Using a biotin-switch assay, we showed that H2S increased S-sulfhydration of SIRT3 and induced deacetylation of its target proteins (OPA1, ATP synthase β, and superoxide dismutase 2). These effects of H2S were associated with a reduction of mitochondrial fragmentation, an increase in ATP generation, and less oxidative injury. Notably, the S-sulfhydration of SIRT3 induced by H2S was abrogated when Cys256, Cys259, Cys280, and Cys283 residues on SIRT3 (two zinc finger domains) were mutated.
Innovation and Conclusion:
Our data suggest that H2S attenuates Cisp-induced AKI by preventing mitochondrial dysfunction via SIRT3 sulfhydrylation. Antioxid. Redox Signal. 31, 1302–1319.
Get full access to this article
View all access options for this article.
References
1.
AhmadA, OlahG, SzczesnyB, WoodME, WhitemanM, and SzaboC. AP39, a mitochondrially targeted hydrogen sulfide donor, exerts protective effects in renal epithelial cells subjected to oxidative stress in vitro and in acute renal injury in vivo. Shock, 45: 88–97, 2016.
2.
AziziF, SeifiB, KadkhodaeeM, and AhghariP. Administration of hydrogen sulfide protects ischemia reperfusion-induced acute kidney injury by reducing the oxidative stress. Ir J Med Sci, 185: 649–654, 2016.
3.
BajwaA, RosinDL, ChroscickiP, LeeS, DondetiK, YeH, KinseyGR, StevensBK, JobinK, KenwoodBM, HoehnKL, LynchKR, and OkusaMD. Sphingosine 1-phosphate receptor-1 enhances mitochondrial function and reduces cisplatin-induced tubule injury. J Am Soc Nephrol, 26: 908–925, 2015.
4.
CaoX, XiongS, ZhouY, WuZ, DingL, ZhuY, WoodME, WhitemanM, MoorePK, and BianJS. Renal protective effect of hydrogen sulfide in cisplatin-induced nephrotoxicity. Antioxid Redox Signal, 29: 455–470, 2018.
5.
ChenY, JinS, TengX, HuZ, ZhangZ, QiuX, TianD, and WuY. Hydrogen sulfide attenuates LPS-induced acute kidney injury by inhibiting inflammation and oxidative stress. Oxid Med Cell Longev, 2018: 6717212, 2018.
6.
ChenY, QingW, SunM, LvL, GuoD, and JiangY. Melatonin protects hepatocytes against bile acid-induced mitochondrial oxidative stress via the AMPK-SIRT3-SOD2 pathway. Free Radic Res, 49: 1275–1284, 2015.
7.
ChengA, YangY, ZhouY, MaharanaC, LuD, PengW, LiuY, WanR, MarosiK, MisiakM, BohrVA, and MattsonMP. Mitochondrial SIRT3 mediates adaptive responses of neurons to exercise and metabolic and excitatory challenges. Cell Metab, 23: 128–142, 2016.
8.
ChengCC, YangYL, LiaoKH, and LaiTW. Adenosine receptor agonist NECA increases cerebral extravasation of fluorescein and low molecular weight dextran independent of blood-brain barrier modulation. Sci Rep, 6: 23882, 2016.
9.
CiarimboliG.Membrane transporters as mediators of cisplatin side-effects. Anticancer Res, 34: 547–550, 2014.
10.
DasariS and TchounwouPB. Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol, 740: 364–378, 2014.
11.
DikalovaAE, ItaniHA, NazarewiczRR, McMasterWG, FlynnCR, UzhachenkoR, FesselJP, GamboaJL, HarrisonDG, and DikalovSI. Sirt3 impairment and SOD2 hyperacetylation in vascular oxidative stress and hypertension. Circ Res, 121: 564–574, 2017.
12.
DuC, LinX, XuW, ZhengF, CaiJ, YangJ, CuiQ, TangC, CaiJ, XuG, and GengB.Sulfhydrated sirtuin-1 increasing its deacetylation activity is an essential epigenetics mechanism of anti-atherogenesis by hydrogen sulfide. Antioxid Redox Signal 7195, 2018.
13.
ElkhwankyMS and HakkolaJ. Extranuclear sirtuins and metabolic stress. Antioxid Redox Signal, 28: 662–676, 2018.
14.
FangY, WangJ, XuL, CaoY, XuF, YanL, NieM, YuanN, ZhangS, ZhaoR, WangH, WuM, ZhangX, and WangJ. Autophagy maintains ubiquitination-proteasomal degradation of Sirt3 to limit oxidative stress in K562 leukemia cells. Oncotarget, 7: 35692–35702, 2016.
15.
FloreaAM and BusselbergD. Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancers, 3: 1351–1371, 2011.
16.
GaoJ, FengZ, WangX, ZengM, LiuJ, HanS, XuJ, ChenL, CaoK, LongJ, LiZ, ShenW, and LiuJ. SIRT3/SOD2 maintains osteoblast differentiation and bone formation by regulating mitochondrial stress. Cell Death Differ, 25: 229–240, 2018.
17.
GaoS, ChenT, ChoiMY, LiangY, XueJ, and WongYS. Cyanidin reverses cisplatin-induced apoptosis in HK-2 proximal tubular cells through inhibition of ROS-mediated DNA damage and modulation of the ERK and AKT pathways. Cancer Lett, 333: 36–46, 2013.
18.
GenovaML and LenazG. The interplay between respiratory supercomplexes and ROS in aging. Antioxid Redox Signal, 23: 208–238, 2015.
19.
GerőD, TorregrossaR, PerryA, WatersA, Le-TrionnaireS, WhatmoreJL, WoodM, and WhitemanM. The novel mitochondria-targeted hydrogen sulfide (H2S) donors AP123 and AP39 protect against hyperglycemic injury in microvascular endothelial cells in vitro. Pharmacol Res, 113: 186–198, 2016.
HeX, ZengH, and ChenJX. Emerging role of SIRT3 in endothelial metabolism, angiogenesis, and cardiovascular disease. J Cell Physiol, 234: 2252–2265, 2019.
22.
HirscheyMD, ShimazuT, JingE, GrueterCA, CollinsAM, AouizeratB, StančákováA, GoetzmanE, LamMM, SchwerB, StevensRD, MuehlbauerMJ, KakarS, BassNM, KuusistoJ, LaaksoM, AltFW, NewgardCB, FareseRVJr, KahnCR, and VerdinE. SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol Cell, 44: 177–190, 2011.
23.
IkedaK, MarutaniE, HiraiS, WoodME, WhitemanM, and IchinoseF. Mitochondria-targeted hydrogen sulfide donor AP39 improves neurological outcomes after cardiac arrest in mice. Nitric Oxide, 49: 90–96, 2015.
24.
InoueT and OkusaMD. Neuroimmune control of acute kidney injury and inflammation. Nephron, 131: 97–101, 2015.
25.
JinL, WeiW, JiangY, PengH, CaiJ, MaoC, DaiH, ChoyW, BemisJE, JirousekMR, MilneJC, WestphalCH, and PerniRB. Crystal structures of human SIRT3 displaying substrate-induced conformational changes. J Biol Chem 284, 2439, 4–24405, 2009.
26.
KarimiA, AbsalanF, KhorsandiL, ValizadehA, and MansouriE. Sodium hydrogen sulfide (NaHS) ameliorates alterations caused by cisplatin in filtration slit diaphragm and podocyte cytoskeletal in rat kidney. J Nephrol, 6: 150–156, 2017.
27.
LiY, YeZ, LaiW, RaoJ, HuangW, ZhangX, YaoZ, and LouT. Activation of sirtuin 3 by silybin attenuates mitochondrial dysfunction in cisplatin-induced acute kidney injury. Front Pharmacol, 8: 178, 2017.
28.
LingQ, YuX, WangT, WangSG, YeZQ, and LiuJH. Roles of the exogenous H2S-mediated SR-A signaling pathway in renal ischemia/reperfusion injury in regulating endoplasmic reticulum stress-induced autophagy in a rat model. Cell Physiol Biochem, 41: 2461–2474, 2017.
29.
LiuZ, LiH, SuJ, XuS, ZhuF, AiJ, HuZ, ZhouM, TianJ, SuZ, YangP, and NieJ. Numb depletion promotes Drp1-mediated mitochondrial fission and exacerbates mitochondrial fragmentation and dysfunction in acute kidney injury. Antioxid Redox Signal, 2017: 7432, 2018.
30.
ManoharS and LeungN. Cisplatin nephrotoxicity: a review of the literature. J Nephrol, 31: 15–25, 2018.
31.
MengG, LiuJ, LiuS, SongQ, LiuL, XieL, HanY, and JiY. Hydrogen sulfide pretreatment improves mitochondrial function in myocardial hypertrophy via a SIRT3-dependent manner. Br J Pharmacol, 175: 1126–1145, 2018.
32.
MódisK, ColettaC, ErdélyiK, PapapetropoulosA, and SzaboC. Intramitochondrial hydrogen sulfide production by 3-mercaptopyruvate sulfurtransferase maintains mitochondrial electron flow and supports cellular bioenergetics. FASEB J, 27: 601–611, 2013.
NaraA, YajimaD, NagasawaS, AbeH, HoshiokaY, and IwaseH. Evaluations of lipid peroxidation and inflammation in short-term glycerol-induced acute kidney injury in rats. Clin Exp Pharmacol Physiol, 43: 1080–1086, 2016.
35.
NohMR, KimKY, HanSJ, KimJI, KimHY, and ParkKM. Methionine sulfoxide reductase A deficiency exacerbates cisplatin-induced nephrotoxicity via increased mitochondrial damage and renal cell death. Antioxid Redox Signal, 27: 727–741, 2017.
36.
OguraY, KitadaM, MonnoI, KanasakiK, WatanabeA, and KoyaD. Renal mitochondrial oxidative stress is enhanced by the reduction of Sirt3 activity, in Zucker diabetic fatty rats. Redox Rep, 23: 153–159, 2018.
37.
PeresLA and da CunhaAD. Jr. Acute nephrotoxicity of cisplatin: molecular mechanisms. J Bras Nefrol, 35: 332–340, 2013.
38.
PericoL, MorigiM, RotaC, BrenoM, MeleC, NorisM, IntronaM, CapelliC, LongarettiL, RottoliD, ContiS, CornaD, RemuzziG, and BenigniA. Human mesenchymal stromal cells transplanted into mice stimulate renal tubular cells and enhance mitochondrial function. Nat Commun, 8: 983, 2017.
39.
PiH, XuS, ReiterRJ, GuoP, ZhangL, LiY, LiM, CaoZ, TianL, XieJ, ZhangR, HeM, LuY, LiuC, DuanW, YuZ, and ZhouZ. SIRT3-SOD2-mROS-dependent autophagy in cadmium-induced hepatotoxicity and salvage by melatonin. Autophagy, 11: 1037–1051, 2015.
40.
QiuX, BrownK, HirscheyMD, VerdinE, and ChenD. Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab, 12: 662–667, 2010.
41.
SalvatoriI, ValleC, FerriA, and CarrìMT. SIRT3 and mitochondrial metabolism in neurodegenerative diseases. Neurochem Int, 109: 184–192, 2017.
42.
SamantSA, ZhangHJ, HongZ, PillaiVB, SundaresanNR, WolfgeherD, ArcherSL, ChanDC, and GuptaMP. SIRT3 deacetylates and activates OPA1 to regulate mitochondrial dynamics during stress. Mol Cell Biol, 34: 807–819, 2014.
43.
SignorileA, SanteramoA, TammaG, PellegrinoT, D'OriaS, LattanzioP, De and RasmoD. Mitochondrial cAMP prevents apoptosis modulating Sirt3 protein level and OPA1 processing in cardiac myoblast cells. BBA-Mol Cell Res, 1864: 355–366, 2017.
44.
SureshbabuA, RyterSW, and ChoiME. Oxidative stress and autophagy: crucial modulators of kidney injury. Redox Biol, 4: 208–214, 2015.
45.
SzczesnyB, MarcattiM, ZatarainJR, DruzhynaN, WiktorowiczJE, NagyP, HellmichMR, and SzaboC. Inhibition of hydrogen sulfide biosynthesis sensitizes lung adenocarcinoma to chemotherapeutic drugs by inhibiting mitochondrial DNA repair and suppressing cellular bioenergetics. Sci Rep, 6: 36125, 2016.
46.
TrabaJ, GeigerSS, Kwarteng-SiawM, HanK, RaOH, SiegelRM, GiusD, and SackMN. Prolonged fasting suppresses mitochondrial NLRP3 inflammasome assembly and activation via SIRT3-mediated activation of superoxide dismutase 2. J Biol Chem, 292: 12153–12164, 2017.
47.
TsengAH, ShiehSS, and WangDL. SIRT3 deacetylates FOXO3 to protect mitochondria against oxidative damage. Free Radic Biol Med, 63: 222–234, 2013.
48.
TsushidaK, TanabeK, MasudaK, TanimuraS, MiyakeH, ArataY, SugiyamaH, and WadaJ. Estrogen-related receptor alpha is essential for maintaining mitochondrial integrity in cisplatin-induced acute kidney injury. Biochem Biophys Res Commun, 498: 918–924, 2018.
49.
UntereinerAA, FuM, MódisK, WangR, JuY, and WuL. Stimulatory effect of CSE-generated H2S on hepatic mitochondrial biogenesis and the underlying mechanisms. Nitric Oxide, 58: 67–76, 2016.
50.
VassilopoulosA, PenningtonJD, AndressonT, ReesDM, BosleyAD, FearnleyIM, HamA, FlynnCR, HillS, RoseKL, KimHS, DengCX, WalkerJE, and GiusD. SIRT3 deacetylates ATP synthase F1 complex proteins in response to nutrient- and exercise-induced stress. Antioxid Redox Signal, 21: 551–564, 2014.
51.
XieL, FengH, LiS, MengG, LiuS, TangX, MaY, HanY, XiaoY, GuY, ShaoY, ParkCM, XianM, HuangY, FerroA, WangR, MoorePK, WangH, and JiY. SIRT3 mediates the antioxidant effect of hydrogen sulfide in endothelial cells. Antioxid Redox Signal, 24: 329–343, 2016.
52.
YangY, LiuH, LiuF, and DongZ. Mitochondrial dysregulation and protection in cisplatin nephrotoxicity. Arch Toxicol Suppl, 88: 1249–1256, 2014.
53.
YaziciA, Sogutlu-SariE, YayA, AksitH, KilicA, AksitD, YildizO, and ErmisSS. The protective effect of selenium in cisplatin-related retinotoxicity. Cutan Ocul Toxicol, 33: 327–332, 2014.
54.
ZhangD, DuJ, TangC, HuangY, and JinH. H2S-induced sulfhydration: biological function and detection methodology. Front Pharmacol, 8: 608, 2017.
55.
ZhangX, RenX, ZhangQ, LiZ, MaS, BaoJ, LiZ, BaiX, ZhengL, ZhangZ, ShangS, ZhangC, Wang 3, CaoL, WangQ, and JiJ. PGC-1α/ERRα-Sirt3 pathway regulates DAergic neuronal death by directly deacetylating SOD2 and ATP synthase beta. Antioxid Redox Signal, 24: 312–328, 2016.
56.
ZhengJ, ShiL, LiangF, XuW, LiT, GaoL, SunZ, YuJ, and ZhangJ. Sirt3 ameliorates oxidative stress and mitochondrial dysfunction after intracerebral hemorrhage in diabetic rats. Front Neurosci, 12: 414, 2018.
57.
ZhouX, FengY, ZhanZ, and ChenJ. Hydrogen sulfide alleviates diabetic nephropathy in a streptozotocin-induced diabetic rat model. J Biol Chem, 289: 28827–28834, 2014.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
